Research Article | DOI: https://doi.org/10.31579/2578-8949/205
1 Head of Marketing and Sales, Riggs Pharmaceuticals, Karachi; Department of Pharmacy, University of Karachi, Pakistan.
2 Assistant Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
3 Assistant Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
4 Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, SBB Dewan University, Karachi, Pakistan.
5 GD Pharmaceutical Inc.; OPJS University, Rajasthan, India.
6 Associate Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
*Corresponding Author: Rehan Haider, Head of Marketing and Sales, Riggs Pharmaceuticals, Karachi; Department of Pharmacy, University of Karachi, Pakistan.
Citation: Rehan Haider, Zameer Ahmed, Hina Abbas, Shabana Naz Shah, Geetha K. Das, et al., (2025), Exosomes: Pioneering the Future of Vitiligo Therapy, Dermatology and Dermatitis, 12(5); DOI:10.31579/2578-8949/205
Copyright: © 2025, Rehan Haider. This is an open-access article distributed under the terms of The Creative Commons. Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 08 December 2025 | Accepted: 20 December 2025 | Published: 30 December 2025
Keywords: influenza A; seasonal disease that is widespread; respiratory infection; fever; viral community; health community broadcast
Influenza A remains a major global health concern. In 2025, we anticipate a significant rise in seasonal outbreaks in various regions. This study examines current trends, clinical symptom patterns, and community-level spread of Influenza A for the 2025 season. The increase in symptoms such as fever, runny nose, sore throat, and body aches has heightened public concern, especially in areas where related illnesses, such as dengue, persist. This review aims to gather new evidence about the spread, symptoms, and factors influencing Influenza A, while also considering its impact on community health and patient care.
Recent dossier shows that Influenza A is circulating as well earlier two age groups. This concede possibility happens, curbing exemptions, changes in the bug, and minor family members getting immunized. The main syndromes involve extreme delirium (over 100°F), nasal blockage, cough, fatigue, and migraine. Importantly, the bacterium spreads fast inside households and communities, chief to local outbreaks.
This paper further argues verdicts from current studies that devote effort to something contamination rates, risk determinants, and the impressed head count. Statistical analysis discloses much taller zeal rates with school-age offspring and occupied men, accompanying migratory peaks occurring from December to February. Effective stop designs, in the way that immunization, early antiviral treatment, and raising society awareness, are important for controlling the virus's spread.
Overall, the results show that Influenza A is expected to be a low-respiratory ailment in 2025, accompanied by clear syndromes and certain spread patterns. Improving following, reinforcing public health ideas, and advancing up-to-date healing judgment can help lower complexities and care for societies.
Influenza A is a significant cause of respiratory disease general and leads to migratory outbreaks occurring [1,2]. In 2025, worldwide surveillance reports accompanied a widespread disease that is widespread disease on account of continuous antigenic changes and variable immunization rates [3,4]. The main syndromes—delirium, diluted nose, cough, and muscle aches—help identify diseases that are widespread from additional feverish diseases like dengue [5,6]. In South Asia, specifically Pakistan and India, an increase in disease that is widespread-like disease has been famous, often looking like dengue, all throughout peak seasons [7]. Recent reports from the WHO and CDC stress that Influenza A debris the chief cause of circulating quickly respiring contaminations all the while colds [8,9]. Understanding allure changing community health is key to directing community health approaches and dispassionate administration [10].
Literature Review
Influenza A commonly meets with antigenic changes, contributing to migratory outbreaks and affecting the cure rate [11,12]. Transmission stands for the most part from household and society spread [13,14]. Studies display that disease that is widespread manifestations are frequently more fundamental and severe than those created by rhinovirus [15]. School-aged youth and active men are key transmitters of the bug [16]. Research also mentions that post-universal shifts in exemption have altered the dispassionate impact of disease that is widespread [17]. Studies from stupidly colonized city districts show greater attack rates on account of close contact [18]. Additionally, research meeting on babies and various seizures discloses various risk factors in groups [19,20].
Statistical Analysis
Epidemiological dossier shows an 18 to 22% increase in disease that is
widespread cases all along the 2025 season, distinguished by older age [21]. Fever above 100°F was noticed in 82 to 91% of lab-habitual cases [22]. Vaccination considerably shortened therapy rates, even though the inclusion criteria differed by domain [23]. Transmission sick between children and young men, connected to patterns of flexibility and cramming [24]. Early antiviral treatment considerably diminished the manifestation event when executed immediately [25].
This narrative review included studies from PubMed, Scopus, WHO FluNet, and CDC following reports from 2018 to 2025 (1–25). Keywords secondhand were “Influenza A,” “society broadcast,” “delirium,” “2025 outbreaks,” and “migratory disease that is widespread.”
Published reports recorded a climbing predominance of Influenza A in 2025 across Asia, Europe, and North America [3,4,8]. The main symptoms included turmoil, dilated nose, cough, and fatigue [6,15]. Household broadcast waited extremely during the whole of [13,14,16]. Vaccination shortened the syndrome, but gaps in inclusion experienced to better spread [12,23]. Surveillance dossier from congested backgrounds like schools and workplaces granted clear clusters of cases [18,24].
Table 1: Common Symptoms of Influenza A and Their Frequency (Based on 2025 Data).
| Symptom | Frequency (%) | Source |
|---|---|---|
| Fever (>100°F) | 82–91 | 14,22 |
| Runny nose | 70–78 | 6,15 |
| Cough | 65–75 | 6,15 |
| Fatigue | 60–70 | 15,22 |
| Headache | 50–60 | 6,14 |
| Body aches / myalgia | 45–55 | 15,22 |
Source: Compiled from published literature and surveillance reports (6,14,15,22).

Source: Nukiwa Souma, N., et al. Influenza Transmission in a Community, all the while a Seasonal Influenza A(H3N2) Outbreak PLOS One. 2012.
Figure 1: Transmission Cycle of Influenza A in Community Settings.
The rise of Influenza A in 2025 indicates a changing, growing study of animal and variable privilege levels [11,12,17]. The noticed syndrome patterns join with prior writings of disease that are widespread clusters [6,8,15,22]. Rapid society broadcast, particularly in sparsely populated fields, further supports former findings on household and uniform spread [13,14,16,18]. Public health measures, including immunization and early antiviral treatment, are productive but are frequently not taken advantage of enough [23,25]. Improved ideas, procedures, and more forceful follow-up systems are important for directing future disease that is widespread waves [1,2,9,10].
Influenza A remains extensive in 2025, giving manifestations like extreme frenzy, diluted nose, cough, and general discomfort [6,15,22]. Its hasty spread in societies entails forceful stop actions, raised immunization rates, and prompt dispassionate operation. Enhanced global following and further research into zealous changes will be detracting from readiness in the up.
Acknowledgment
The authors gratefully acknowledge the guidance of Dr. Naweed Imam Syed, Professor of Cell Biology at the University of Calgary, for his invaluable insights and mentorship throughout this work.
Authors’ Contribution
All authors contributed to the conception, design, analysis, and writing of this manuscript. Each author reviewed and approved the final version for publication.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,